What urinary metanephrine (or normetanephrine) level is diagnostic for pheochromocytoma?

Diagnostic Urinary Metanephrine Threshold for Pheochromocytoma

A 24-hour urine total metanephrine level above 1,800 mcg (or μg) is almost always diagnostic for pheochromocytoma in the appropriate clinical setting 1.

Biochemical Diagnostic Approach

Primary Screening Test

While the AACE/AAES guidelines establish the 1,800 mcg/24-hour threshold for urinary total metanephrines, plasma free metanephrines and normetanephrines measured by LC-MS/MS after 30 minutes supine rest represent the superior initial screening test, with sensitivity of 97-100% and specificity of 85-89% 1, 2. This is particularly important because:

• Urinary measurements have a higher false-negative rate compared to plasma
• Plasma measurements have a higher false-positive rate but better sensitivity
• The measurement method matters significantly—LC-MS/MS outperforms immunoassays 2

Diagnostic Thresholds by Test Type

For 24-hour urine:

• Total metanephrines >1,800 mcg: Almost always diagnostic 1
• Combined metanephrine + normetanephrine ≥2× upper normal limit (UNL): 98.3% of confirmed pheochromocytomas fall above this threshold 3
• Positive predictive values increase with higher elevations:
  • ≥2× UNL: 42% PPV
  • ≥2.5× UNL: 55% PPV
  • ≥3× UNL: 69% PPV 3

For plasma free metanephrines:

• Exceeding 3-4× normal: Highly diagnostic 1
• ≥2× UNL measured by LC-MS/MS after 30-minute supine rest: Confirms diagnosis in small tumors that may show normal/borderline urine levels 4

Critical Clinical Algorithm

Step 1: Pre-analytical Considerations

Discontinue interfering medications 1-2 weeks before testing to avoid false-positives 1:

• Tricyclic antidepressants
• Decongestants/amphetamines
• Reserpine
• Phenoxybenzamine (ironically used for treatment)
• Norepinephrine reuptake blockers cause dose-dependent elevations 5

Step 2: Choose Initial Test Based on Clinical Context

For adrenal incidentalomas (most common presentation—52.5% of cases 3):

• Start with plasma free metanephrines by LC-MS/MS after 30-minute supine rest 2, 4
• If unavailable, use 24-hour urine fractionated metanephrines
• CT attenuation ≥19 Hounsfield units increases pretest probability significantly 6

For symptomatic patients:

• Either test acceptable, but plasma preferred for sensitivity
• Note: Only 10% present with classic triad (headache, palpitations, sweating) 3
• 15% have no hypertension history 1

Step 3: Interpret Results

Diagnostic (proceed to imaging and surgery prep):

• Urine total metanephrines >1,800 mcg/24h 1
• Plasma metanephrines >3-4× UNL 1
• Plasma metanephrines ≥2× UNL by LC-MS/MS with proper sampling 4

Borderline (1.5-2× UNL):

• Repeat testing with optimal conditions
• Consider plasma testing if urine was initial test
• For small tumors (<2 cm), plasma may be positive when urine is normal 4

Important Caveats and Pitfalls

Sampling Position Matters Critically

Blood drawn seated vs. supine can cause:

• 2.8-fold increase in false-positives with seated sampling 2
• 3-fold increase in false-negatives if using seated reference ranges 2
• Patients with pheochromocytoma do not show posture-related increases, but normal patients do 2

Small Tumors Can Be Biochemically Subtle

• 21% of pheochromocytomas are "biochemically silent" 7
• Small incidentalomas may show normal 24-hour urine but elevated plasma levels 4
• Do not rely solely on urine testing for small (<2 cm) lipid-poor adrenal masses 4

Measurement Method Quality

• LC-MS/MS or LC-ECD significantly outperform immunoassays 2
• Immunoassays underestimate concentrations and have lower sensitivity 2
• If only immunoassay available, consider sending samples to reference laboratory with LC-MS/MS capability

Normetanephrine vs. Metanephrine

• Normetanephrine (from norepinephrine) is more commonly elevated
• Plasma normetanephrine >2× UNL is rare (2.3%) in head/neck paragangliomas but suggests extra-adrenal disease 8
• Urine normetanephrine-to-creatinine ratio shows 78.9% sensitivity and 76.9% specificity 7

The 1,800 mcg/24-hour threshold remains the established diagnostic cutoff for urinary total metanephrines, but modern practice increasingly favors plasma free metanephrines measured by LC-MS/MS under controlled conditions as the initial test, particularly for small or incidental tumors where urine testing may be falsely negative.